|
|
|
|
|
by Lanthanide
2638 days ago
|
|
This is fascinating, and a niche where I can definitely see a smaller player causing a splash and driving down prices for nuclear medicine. My question is, how equipped are you to handle regulatory hurdles for international customers? It's one thing for a small firm to deal with US civil nuclear regulations, but how are you going to deal with the regulators of each foreign market you intend to export to? I imagine that this is something that the larger providers in the field use economies of scale to deal with, but could be a hurdle for a startup. |
|
Regardless, that is an important issue, but one I don't have to have a solid answer to for several years.
Great username, btw. ;)